Latest osteosarcoma Stories
NEW YORK, April 29 /PRNewswire-USNewswire/ -- The Sarcoma Foundation of America (SFA)'s Eighth Annual Fundraising Gala on Monday, April 26, raised more than $925,000, an all-time record for the non-profit group dedicated to increasing research that will find new and better therapies for patients with sarcoma, a rare connective tissue cancer. Funding from the Gala directly supports grants for sarcoma researchers and assists with education and advocacy initiatives on behalf of sarcoma...
Nine-year-old Morgan LaRue is the first cancer patient in Texas to benefit from a groundbreaking procedure that will magnetically lengthen her leg, sparing her the possibility of up to 10 future surgeries as her body grows. The implant and extension took place at Texas Children's Cancer Center in Houston, Texas. On March 29, 2010, Morgan lost a portion of the bone in her upper leg to osteosarcoma (bone cancer) and was facing the potential of numerous surgeries in order to keep her left...
TGen and VARI study cancer in dogs to find new treatments for humansFido's wet licks might hold more than love. They could provide the DNA keys to findings new treatments for rare cancers and other diseases in both dogs and human patients.The Translational Genomics Research Institute (TGen) and the Van Andel Research Institute (VARI) have created the Canine Hereditary Cancer Consortium, a program designed to study naturally occurring cancers in dogs to better understand why both pets and...
Dr. Tsz-Kwong Man, a researcher with the Texas Children's Cancer Center at Baylor College of Medicine, has a received a grant from the Liddy Shriver Sarcoma Initiative to study the function of a protein that may promote the spread of a common form of children's bone cancer called osteosarcoma."This is a devastating cancer," said Man, principal investigator of the study. "Once the cancer spreads to other parts of the body, and it often does, it can be very aggressive and has...
A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer. The study drug, Bortezomib, was found to be effective against bone cancer in human cancer cell studies and in mice. While key experiments were in animals, the cancer studied closely resembled the human form and the drug has already been proven to be safe in human...
SAN MARINO, Calif., Oct. 12 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic. Administered as stand-alone therapy in late-stage cases of chemotherapy-resistant cancer, Rexin-G has once again accomplished what standard cancer treatments and even much-touted biologics have failed to do: that is, to bring forth...
A team of Israeli researchers say they have developed a new drug carrier to deliver compounds straight to a tumor to starve it of blood. Dr. Ronit Satchi-Fainaro of Tel Aviv University's Sackler School of Medicine said that like folklore's blood-sucking vampires, cancer tumors require an ample supply of blood to stay alive. Without fresh blood for sustenance, cancer cells shrivel up like raisins and die. Satchi-Fainaro and her team said the new invention that ferries a variety of existing...
New TAU drug cuts off blood supplies to starve cancer tumorsLike vampires, cancer tumors require an ample supply of blood to stay alive. Without fresh blood for sustenance, cancer cells shrivel up like raisins and die.To that end, Dr. Ronit Satchi-Fainaro of Tel Aviv University's Department of Physiology and Pharmacology, Sackler School of Medicine, and her team of researchers have developed a new drug carrier to deliver compounds straight to the tumor. Ferrying a variety of existing...
ROCKLEIGH, N.J., Sept. 2 /PRNewswire/ -- Volvo Cars of North America (VCNA) is teaming up with Alex's Lemonade Stand Foundation (ALSF) during National Childhood Cancer Awareness Month to help families gain easier access to care and clinical trials at hospitals outside of their hometown. (Logo: http://www.newscom.com/cgi-bin/prnh/20090612/LA31208LOGO) Throughout September, donations made on Volvo's Virtual Lemonade Stand, www.lemonadestandforlife.com, will go to ALSF's Travel Fund, which...
A new analysis suggests patients and physicians should rethink the pros and cons of limb-sparing surgery versus amputation for bone and soft tissue sarcomas of the lower limb.Patients with tumors of the bone or soft tissue in their arms and legs require surgery to remove their cancer. To compare the costs and benefits of amputation compared with limb-sparing surgery in these patients, Canadian researchers Ronald Barr, M.D., M.B., Ch.B., of McMaster University and Jay Wunder, M.D., M.Sc., of...
